Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Piramal Enterprises...

    Piramal Enterprises Partners with IPA to Educate Stakeholders on Responsible Self-Care

    Written by supriya kashyap kashyap Published On 20 April 2017 6:10 AM  |  Updated On 20 April 2017 6:10 AM

    Mumbai : Piramal Enterprises Consumer Products business has partnered with the Indian Pharmaceutical Association (IPA), to promote responsible self-care to over 5,000 chemists in India, starting in the Eastern region. In line with Piramal Group’s values of Knowledge, Action, Care and Impact, the initiative has been undertaken to provide educational information and spread awareness to pharmacists and the public on responsible self-care. IPA is the national professional body of pharmacists engaged in various facets of pharmacy.


    Piramal Enterprises is committed to promoting the highest professional and ethical standards in pharmacies. The focus of the partnership is to establish pharmacists as competent healthcare professionals. As part of the activity, Piramal Enterprises and IPA jointly will organize Chemist Awareness Programmes (CAP) in different locations across India. This programme will focus on ‘responsible self-care’, and chemists will be certified by IPA based on their performance. Through this partnership, both Piramal Enterprises and IPA will host an array of speaker series where professionals from the industry will discuss on various aspects of self-care.


    Self–medication is a common practice in India. Through this programme, Piramal Enterprises will work towards increasingawareness on the adverse side-effects of self-medication. This partnership will equip pharmacists’to distinguish between ailments that require the doctor’s attention and need treatment with prescription medicines,versus minor ailments that can be treated with over the counter solutions.


    Kedar Rajadnye, Chief Operating Officer Consumer Products, Piramal Enterprises said, “At Piramal, our objective is to empower consumers to treat their needs causes that can disrupt their daily routines, at their convenience. The first step towards achieving this is by educating chemists on responsible self-care. In India, consumers are unware of the side effects of self-medication and depend on chemists for advice. This association with the IPA, is a testament to Piramal Enterprises’ vision of educating consumers with dedicated and legitimate information on responsible self-care.”


    Manjiri Gharat, Vice-President and Chairperson, Community Pharmacy Division of Indian Pharmaceutical Association (IPA) said, “We are delighted and privileged to be associated with Piramal Enterprises, since the collaboration plans to work towards educating consumers on the right aspects of self–medication by training of community pharmacists who are the first point of contact for the consumers/patients. This activity will highlight pharmacists as a source for primary care. They can advise, and increase awareness on the correct use of medications, based on their knowledge of medicine, and their effect on the body.”

    Chemist Awareness ProgrammeIndian Pharmaceutical AssociationKedar RajadnyeManjiri GharatPiramal
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok